Metastatic hormone-naïve prostate cancer: a distinct biological entity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metastatic hormone-naïve prostate cancer: a distinct biological entity

Published:2024-09 Issue:9 Volume:10 Page:825-841
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Corres-Mendizabal Jon^ORCID,Zacchi Francesca^ORCID,Martín-Martín Natalia^ORCID,Mateo Joaquin,Carracedo Arkaitz^ORCID

Publisher

Elsevier BV

Reference138 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Metastatic prostate cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer;Buzzoni;Eur. Urol.,2015

3. Estimating the number of men living with metastatic prostate cancer in the United States;Devasia;Cancer Epidemiol. Biomarkers Prev.,2023

4. High rates of advanced prostate cancer in the Middle East: analysis from a tertiary care center;Daher;Urol. Ann.,2021

5. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group;Zhou;Int. J. Cancer,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3